Phenomic AI

QuirieGen

This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.

Biodock

This company provides a cloud-based artificial intelligence platform for microscopy image analysis, serving pharmaceutical companies and academic research institutions.

Scailyte

This company develops artificial intelligence software for single-cell data analysis and biomarker discovery for pharmaceutical, clinical and academic research customers.

BenchSci

This company provides an artificial intelligence platform for preclinical research and drug discovery to pharmaceutical companies and academic research institutions.

Envisagenics

This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.